Ramius Advisors’s SCP & CO Healthcare Acquisition Company Warrant SHACW Stock Holding History

Ramius Advisors’s Portfolio SHACW Stock Details SHACW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-197,901	Closed	-$10K	–	270
2022 Q3	$10K	Buy	197,901 +3,774	+2%	+$188	﹤0.01%	126
2022 Q2	$16K	Buy	+194,127	New	+$27.1K	0.01%	145
2022 Q1	–	Sell	-194,127	Closed	-$107K	–	287
2021 Q4	$107K	Buy	194,127 +15,076	+8%	+$8.87K	0.04%	225
2021 Q3	$104K	Buy	179,051 +51,811	+41%	+$36.6K	0.06%	140
2021 Q2	$108K	Buy	127,240 +107,240	+536%	+$68.5K	0.04%	211
2021 Q1	$12K	Buy	+20,000	New	+$12.3K	﹤0.01%	332

Ramius Advisors's SHACW Position: Q4 2022 in Review

Ramius Advisors sold out of SCP & CO Healthcare Acquisition Company Warrant (SHACW) in Q4 2022, closing a stake of 197,901 shares — an estimated $10K sold.

Ramius Advisors first reported a position in SHACW in Q1 2021 and held it in 6 quarters. The position peaked at $108K in Q2 2021. 0 funds tracked by Wall St. Rank hold SHACW as of Q4 2022.

Ramius Advisors reported no remaining SCP & CO Healthcare Acquisition Company Warrant position as of Q4 2022 after selling out during the quarter.
Ramius Advisors sold 197,901 SCP & CO Healthcare Acquisition Company Warrant shares in Q4 2022, an estimated $10K.
Ramius Advisors first reported a position in SCP & CO Healthcare Acquisition Company Warrant in Q1 2021 and held it in 6 quarters.
Ramius Advisors's SCP & CO Healthcare Acquisition Company Warrant position peaked at $108K in Q2 2021.
0 funds tracked by Wall St. Rank held SCP & CO Healthcare Acquisition Company Warrant as of Q4 2022.

Based on Ramius Advisors's 13F filing for Q4 2022, filed 13 Feb 2023.